http://www.analyticamedical.com/downloads/2013/20130828-Wiseowl-Analytica-ALT-Aug2013.pdf
Wise-owl continues to recommend medical device company Analytica (ALT) with a 'speculative buy' as it moves into the growing m-Health market.
On the verge of selling its female incontinence device PeriCoach.
Global market worth in excess of $5 billion.
PeriCoach allows Analytica to enter the fast growing m-Health market.
Revised target of 7.6c, upside of more than 260% from current levels.
- Forums
- ASX - By Stock
- ALT
- wiseowl research - 7.6c buy recommendation
wiseowl research - 7.6c buy recommendation
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online